EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Epigenetic reader chromodomain as a potential therapeutic target

Shivangi Sharma iD, J Trae Hampton iD, Tatiana G Kutateladze iD, Wenshe Ray Liu iD

RSC Chemical Biology · 2025 · 6 (6) · 833-844

DOI: 10.1039/d4cb00324a ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RSC Chemical Biology, 2025. Verfasst von Shivangi Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Texas A&M Drug Discovery Center and Department of Chemistry, Texas A&M University College Station TX 77843 USA wsliu2007@tamu.edu. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chromodomains are epigenetic readers for histone methylation. Their selective targeting by small molecule or peptide inhibitors may serve as a novel way for disease intervention.

Autor:innen und Institutionen

  • Texas A&M Drug Discovery Center and Department of Chemistry, Texas A&M University College Station TX 77843 USA wsliu2007@tamu.edu.
  • Department of Pharmacology, University of Colorado School of Medicine Aurora CO 80045 USA tatiana.kutateladze@cuanschutz.edu.
  • Institute of Biosciences and Technology and Department of Translational Medical Sciences, College of Medicine, Texas A&M University Houston TX 77030 USA.
  • Department of Biochemistry and Biophysics, Texas A&M University College Station TX 77843 USA.
  • Department of Cell Biology and Genetics, College of Medicine, Texas A&M University College Station TX 77843 USA.
  • Department of Pharmaceutical Sciences, Texas A&M University College Station TX 77843 USA.

ORCID-Profile: Shivangi Sharma, J Trae Hampton, Tatiana G Kutateladze, Wenshe Ray Liu

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIA NIH HHS
  • Welch Foundation
  • Cancer Prevention and Research Institute of Texas
  • National Institutes of Health

Zitieren

APA

Sharma, S., Hampton, J. T., Kutateladze, T. G., & Liu, W. R. (2025). Epigenetic reader chromodomain as a potential therapeutic target. RSC Chemical Biology, 6(6), 833-844. https://doi.org/10.1039/d4cb00324a

Vancouver

Sharma S, Hampton JT, Kutateladze TG, Liu WR. Epigenetic reader chromodomain as a potential therapeutic target. RSC Chemical Biology. 2025;6(6):833-844. doi:10.1039/d4cb00324a

BibTeX
@article{Sharma2025,
  author = {Sharma, Shivangi and Hampton, J Trae and Kutateladze, Tatiana G and Liu, Wenshe Ray},
  title = {Epigenetic reader chromodomain as a potential therapeutic target},
  journal = {RSC Chemical Biology},
  year = {2025},
  volume = {6},
  number = {6},
  pages = {833--844},
  doi = {10.1039/d4cb00324a}
}
Kostenlos starten →